US EditionIntegrated Theranostics Solutions and Bridge Oncology Launch Turnkey Theranostics Program to Help Fast-Track Radioligand Therapy Adoption
- Integrated Theranostics Solutions and Bridge Oncology have formed a strategic partnership to offer a full-service theranostics program.
- This collaboration provides oncology clinics and health systems with the necessary tools to implement theranostics efficiently.
- The global theranostics market is projected to grow from $4.3 billion in 2024 to $12.7 billion by 2029, increasing pressure on healthcare organizations.
- The partnership aims to enhance patient care through better tumor characterization and personalized treatment plans.
Insights by Ground AI
Does this summary seem wrong?
34 Articles
34 Articles
All
Left
1
Center
7
Right
8
Bennington Banner+33 Reposted by 33 other sources
Integrated Theranostics Solutions and Bridge Oncology Launch Turnkey Theranostics Program to Help Fast-Track Radioligand Therapy Adoption
PADUCAH, Ky., June 20, 2025 /PRNewswire/ -- Integrated Theranostics Solutions (ITS) and Bridge Oncology today announced a strategic partnership that brings together two leading consulting service providers to offer the market's only full-service, end-to-end solution for building and scaling theranostics…
Coverage Details
Total News Sources34
Leaning Left1Leaning Right8Center7Last UpdatedBias Distribution50% Right
Bias Distribution
- 50% of the sources lean Right
50% Right
C 44%
R 50%
Factuality
To view factuality data please Upgrade to Premium
